MJH Logo
Last Updated On: August 23, 2016
  • Access
  • Access
  • Insight
  • Education
  • Access
  • Insight
  • Education
  • Access
  • Insight
  • Education
Products, Services, & Partnerships
The future of Lung Cancer The future of Breast Cancer PER Event PER Event PER Event ONCLive SOSS AJMC AMCO SOGO NYGU NYGU PCDC Per Event 34 Chemotherapy Foundation VBOnc GBM SOBO Miami Lung Cancer Miami Breast Cancer Giants 2016 MD Mag Pharmacy Times Pharmacy Times RDR OncLive SAP Pharmacy Times
A Full-Service Healthcare Communications Company
 
Michael J. Hennessy Associates‚ Inc‚ is dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. As a full-service healthcare communications company‚ MJH Associates provides integrated communication products and services, education, and research to the healthcare industry. 
 
Within our integrated communications division, we feature an established‚ comprehensive network of print and digital products that reaches an impressive array of healthcare decision makers, including physicians, pharmacists, managed care professionals, PA/NPs, nurses, and patients. Michael J. Hennessy Associates, Inc, has a long-standing reputation for offering timely, relevant, and practical information that meets the needs of our diverse audience.
 
As a company, Michael J. Hennessy Associates, Inc, combines the reach and influence of its powerful portfolio of print and digital product line, live events, educational programs, and custom market research with the customer service focus and customization capabilities of a boutique firm. Our clients include world-leading pharmaceutical, medical device, diagnostic, and biotech companies within the industry.

Leading Brands, Broadest Reach
The American Journal of Accountable CareFamily Practice RecertificationThe American Journal of Managed CareThe American Journal of Pharmacy BenefitsArcmesaCardiology Review OnlineContemporary OncologyCure TodayDentists' Money DigestOncology Business ManagementPharmacy TimesGiants of Cancer CareOncology FellowsAmerican Journal of Hematology / OncologyInternal Medicine World ReporCure ConnectionsIntellisphereMD MagazineContemporary ClinicResident and Staff PhyisicianPhysician's Money DigestOncologueMedical CrossfireInteractive PublicationsSurgical RoundsPhysicians Financial newsMedical World NewsOncLiveEvidence-Based OncologyRare Disease CommunicationsPain ManagementPharmacy Times Continuing EducationOncLive InsightsRare Disease ReportThe Educated PatientOncology and Biotech NewsHRA ResearchOncLive News NetworkSpecialty Pharmacy TimesPhysicians Education ResourceOncLive Peer ExchangeUrologists in Cancer CareOncology Nursing NewsMD MagazineTargeted Oncology
The Latest
from MJH Associates

Pharmacy Times Partners with Infectious Disease Pharmacists
Pharmacy Times and the Society of Infectious Diseases Pharmacists (SIDP) have established a strategic partnership to provide antimicrobial expertise and infectious disease education to pharmacists.

PER Announces World-Renowned Medical Technology Expert Dr. Atul Butte as the Keynote Speaker for the 34th Annual Chemotherapy Foundation Symposium
The 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow (CFS) has announced that Atul Butte, MD, PhD, will deliver the keynote address at its annual meeting in November. Dr. Butte is recognized as a global expert in clinical informatics, a field that is guiding practitioners toward delivering more effective chemotherapy and other treatments for cancer and a range of other diseases.

Evidence-Based Oncology Looks at How the Cost of Cancer Care Affects Treatment
At what point does the cost of cancer therapy affect the results? The current issue of Evidence-Based Oncology, a publication of The American Journal of Managed Care, takes on one of today's biggest treatment challenges: the eye-popping prices of today's new therapies can erect barriers to care before it begins.


Our Audience